BACKGROUND: Tuberculosis remains a serious global health problem involving one-third of the world population. A wide diversity of Mycobacterium tuberculosis strains cause about 1.5 million deaths/year worldwide, but in developing countries, the genetic diversity of M. tuberculosis strains remains largely unknown. We conducted a first insight into the population diversity of M. tuberculosis strains from Tamaulipas, Mexico. METHODS: Seventy-two M. tuberculosis strains were identified and genetic diversity determined by spoligotyping. Drug sensibility testing and punctual mutations in inhA, ahpC, rpoB, and katG genes were assessed. RESULTS: Spoligotyping analysis showed a higher prevalence of LAM9 > T1 > Haarlem3 subfamilies among 53 spoligotype patterns. Unexpectedly, five Beijing strains conforming four unique spoligopatterns were recovered. The more frequently isolated strains (LAM9 and T1), but none of the Beijing strains, were found resistant to INH or RIF. Also, no drug resistance was found among Haarlem3 isolates. The katG(315) gene mutation was found in 83% of INH-resistant strains, whereas rpoB(526) were associated in only 43% of RIF M. tuberculosis drug-resistant strains. CONCLUSIONS: This and other studies report a high rate of orphan spoligotypes, which highlights the need for genotyping implementation as a routine technique for better understanding of M. tuberculosis strains in developing countries such as Mexico.
BACKGROUND: Tuberculosis remains a serious global health problem involving one-third of the world population. A wide diversity of Mycobacterium tuberculosis strains cause about 1.5 million deaths/year worldwide, but in developing countries, the genetic diversity of M. tuberculosis strains remains largely unknown. We conducted a first insight into the population diversity of M. tuberculosis strains from Tamaulipas, Mexico. METHODS: Seventy-two M. tuberculosis strains were identified and genetic diversity determined by spoligotyping. Drug sensibility testing and punctual mutations in inhA, ahpC, rpoB, and katG genes were assessed. RESULTS: Spoligotyping analysis showed a higher prevalence of LAM9 > T1 > Haarlem3 subfamilies among 53 spoligotype patterns. Unexpectedly, five Beijing strains conforming four unique spoligopatterns were recovered. The more frequently isolated strains (LAM9 and T1), but none of the Beijing strains, were found resistant to INH or RIF. Also, no drug resistance was found among Haarlem3 isolates. The katG(315) gene mutation was found in 83% of INH-resistant strains, whereas rpoB(526) were associated in only 43% of RIF M. tuberculosis drug-resistant strains. CONCLUSIONS: This and other studies report a high rate of orphan spoligotypes, which highlights the need for genotyping implementation as a routine technique for better understanding of M. tuberculosis strains in developing countries such as Mexico.
Authors: Olga S Toungoussova; Per Sandven; Andrey O Mariandyshev; Nina I Nizovtseva; Gunnar Bjune; Dominique A Caugant Journal: J Clin Microbiol Date: 2002-06 Impact factor: 5.948
Authors: José María Viader-Salvadó; Claudia Maribel Luna-Aguirre; Jorge Mauricio Reyes-Ruiz; Ramón Valdez-Leal; Maria de los Angeles del Bosque-Moncayo; Rolando Tijerina-Menchaca; Martha Guerrero-Olazarán Journal: Microb Drug Resist Date: 2003 Impact factor: 3.431
Authors: Olga S Toungoussova; Dominique A Caugant; Per Sandven; Andrey O Mariandyshev; Gunnar Bjune Journal: FEMS Immunol Med Microbiol Date: 2004-11-01
Authors: E Garza-González; G M González; A Rentería; W Cruz-Pulido; G Rivera; V Bocanegra-García Journal: Clin Microbiol Infect Date: 2009-08-07 Impact factor: 8.067
Authors: Elizabeth Nava-Aguilera; Yolanda López-Vidal; Eva Harris; Arcadio Morales-Pérez; Steven Mitchell; Miguel Flores-Moreno; Ascencio Villegas-Arrizón; José Legorreta-Soberanis; Robert Ledogar; Neil Andersson Journal: Clin Dev Immunol Date: 2010-12-08
Authors: Karine Brudey; Jeffrey R Driscoll; Leen Rigouts; Wolfgang M Prodinger; Andrea Gori; Sahal A Al-Hajoj; Caroline Allix; Liselotte Aristimuño; Jyoti Arora; Viesturs Baumanis; Lothar Binder; Patricia Cafrune; Angel Cataldi; Soonfatt Cheong; Roland Diel; Christopher Ellermeier; Jason T Evans; Maryse Fauville-Dufaux; Séverine Ferdinand; Dario Garcia de Viedma; Carlo Garzelli; Lidia Gazzola; Harrison M Gomes; M Cristina Guttierez; Peter M Hawkey; Paul D van Helden; Gurujaj V Kadival; Barry N Kreiswirth; Kristin Kremer; Milan Kubin; Savita P Kulkarni; Benjamin Liens; Troels Lillebaek; Minh Ly Ho; Carlos Martin; Christian Martin; Igor Mokrousov; Olga Narvskaïa; Yun Fong Ngeow; Ludmilla Naumann; Stefan Niemann; Ida Parwati; Zeaur Rahim; Voahangy Rasolofo-Razanamparany; Tiana Rasolonavalona; M Lucia Rossetti; Sabine Rüsch-Gerdes; Anna Sajduda; Sofia Samper; Igor G Shemyakin; Urvashi B Singh; Akos Somoskovi; Robin A Skuce; Dick van Soolingen; Elisabeth M Streicher; Philip N Suffys; Enrico Tortoli; Tatjana Tracevska; Véronique Vincent; Tommie C Victor; Robin M Warren; Sook Fan Yap; Khadiza Zaman; Françoise Portaels; Nalin Rastogi; Christophe Sola Journal: BMC Microbiol Date: 2006-03-06 Impact factor: 3.605
Authors: Racquel Domingo-Gonzalez; Shibali Das; Kristin L Griffiths; Mushtaq Ahmed; Monika Bambouskova; Radha Gopal; Suhas Gondi; Marcela Muñoz-Torrico; Miguel A Salazar-Lezama; Alfredo Cruz-Lagunas; Luis Jiménez-Álvarez; Gustavo Ramirez-Martinez; Ramón Espinosa-Soto; Tamanna Sultana; James Lyons-Weiler; Todd A Reinhart; Jesus Arcos; Maria de la Luz Garcia-Hernandez; Michael A Mastrangelo; Noor Al-Hammadi; Reid Townsend; Joan-Miquel Balada-Llasat; Jordi B Torrelles; Gilla Kaplan; William Horne; Jay K Kolls; Maxim N Artyomov; Javier Rangel-Moreno; Joaquín Zúñiga; Shabaana A Khader Journal: JCI Insight Date: 2017-10-05